CytomX Therapeutics CTMX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$17.37M-154% | $31.87M— | —— | -$99.32M+14.3% | ||
| $6.3M-17.8% | $7.67M-10.4% | $8.56M-19.5% | $10.63M-19.3% | ||
| -$75.59M+12.3% | -$86.23M-53.9% | -$56.04M+49.4% | -$110.79M+6.9% | ||
| —— | $310K-63.1% | $840K-51.7% | $1.74M+8.1% | ||
| -$60.18M-160% | $99.7M— | —— | $98.26M— | ||
| $110.45M+1,368% | $7.52M-75.1% | $30.23M+4,565% | $648K-99.4% | ||
| -$24.89M— | —— | -$177.66M— | —— | ||
| -$75.81M+12.4% | -$86.54M-52.2% | -$56.88M+49.5% | -$112.53M+6.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CytomX Therapeutics generate?
- CytomX Therapeutics (CTMX) generated -$80.1M in operating cash flow over the trailing twelve months.
- What is CytomX Therapeutics's free cash flow?
- After $347.0K of capital expenditures, CytomX Therapeutics's free cash flow was -$80.2M over the trailing twelve months, up 1.7% year over year.
- Where does CytomX Therapeutics's cash flow data come from?
- Every line is extracted from CytomX Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
